Management of Candida endocarditis.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 5008109)

Published in J Thorac Cardiovasc Surg on January 01, 1972

Authors

T M Grehl, L H Cohn, W W Angell

Articles by these authors

The value of the autopsy in three medical eras. N Engl J Med (1983) 7.00

Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation (1996) 4.40

Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med (1999) 2.19

Thoracoscopic transmyocardial laser revascularization. Ann Thorac Surg (1997) 2.02

Multiple valve replacement with the fresh aortic homograft. J Thorac Cardiovasc Surg (1968) 1.90

The bidirectional cavopulmonary shunt. J Thorac Cardiovasc Surg (1990) 1.89

Impact of body mass index and albumin on morbidity and mortality after cardiac surgery. J Thorac Cardiovasc Surg (1999) 1.87

Left ventricular ejection fraction as a prognostic guide in surgical treatment of coronary and valvular heart disease. Am J Cardiol (1974) 1.67

Guidelines for reporting morbidity and mortality after cardiac valvular operations. The American Association for Thoracic Surgery, Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity. Ann Thorac Surg (1996) 1.67

Single-clamp technique: an important adjunct to myocardial and cerebral protection in coronary operations. Ann Thorac Surg (1994) 1.61

Axilloaxillary cardiopulmonary bypass: a practical alternative to femorofemoral bypass. Ann Thorac Surg (1997) 1.57

Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation (2001) 1.56

Aortic valve operations under deep hypothermic circulatory arrest for the porcelain aorta: "no-touch" technique. Ann Thorac Surg (1998) 1.53

Guidelines for reporting morbidity and mortality after cardiac valvular operations. Eur J Cardiothorac Surg (1988) 1.50

Operative treatment of atrial septal defect: clinical and haemodynamic assessments in 175 patients. Br Heart J (1967) 1.47

Sequentially paced heterotopic heart transplant in the left chest provides improved circulatory support for the failed left ventricle. A potential biologic bridge to orthotopic transplantation. J Thorac Cardiovasc Surg (1989) 1.46

Surgical treatment of adult atrial septal defect: early and long-term results. J Am Coll Cardiol (1992) 1.44

Hypokalemia and electrocardiographic abnormalities during acute alcohol withdrawal. Arch Intern Med (1967) 1.43

Favorable results of coronary artery bypass grafting in patients older than 75 years. J Thorac Cardiovasc Surg (1990) 1.43

Changes in vein grafts following aorto-coronary bypass induced by pressure and ischemia. J Thorac Cardiovasc Surg (1972) 1.42

Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity of The American Association for Thoracic Surgery and The Society of Thoracic Surgeons. J Thorac Cardiovasc Surg (1996) 1.41

LV-powered coronary sinus retroperfusion reduces infarct size in acutely ischemic pigs. Ann Thorac Surg (2000) 1.38

Pulmonary autograft--past, present, and future. J Heart Valve Dis (1993) 1.34

Coronary artery spasm. medical management, surgical denervation, and autotransplantation. J Thorac Cardiovasc Surg (1977) 1.33

Percutaneous transvenous endomyocardial biopsy. JAMA (1973) 1.33

Morphology of fresh heart valve homografts. Surgery (1969) 1.31

Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation (1974) 1.27

Dissection of the thoracic aorta. Medical or surgical therapy? Am J Cardiol (1974) 1.26

Progress in transplantation of the heart. Transplantation (1967) 1.25

Mitral valve replacement with the fresh aortic valve homograft: experimental results and clinical application. Surgery (1967) 1.24

Elliot Carr Cutler mitral valve surgery at Peter Bent Brigham Hospital 1923. J Card Surg (1994) 1.17

Reoperative aortic valve replacement: partial upper hemisternotomy versus conventional full sternotomy. J Thorac Cardiovasc Surg (1999) 1.16

Determinants of survival following cardiac operations in elderly patients. Chest (1975) 1.15

Coronary bypass grafting with totally calcified or acutely dissected ascending aorta. Ann Thorac Surg (1991) 1.14

Repair of mitral regurgitation from myxomatous degeneration in the patient with a severely calcified posterior annulus. J Card Surg (1995) 1.14

Small vessel replacement with gore-tex (expanded polytetrafluoroethylene). Arch Surg (1976) 1.14

Hemodynamic determinants of prognosis of aortic valve replacement in critical aortic stenosis and advanced congestive heart failure. Circulation (1980) 1.13

The cost of treating heart valve related complications. J Heart Valve Dis (1996) 1.13

Emergency coronary artery bypass. Surgery (1971) 1.10

The preferred approach for mitral valve surgery after CABG: right thoracotomy, hypothermia and avoidance of LIMA-LAD graft. J Heart Valve Dis (2001) 1.09

The future of cardiology: utilization and costs of care. J Am Coll Cardiol (2000) 1.09

Twelve-year experience with glutaraldehyde-preserved porcine xenografts. J Thorac Cardiovasc Surg (1982) 1.08

Results of reoperation for recurrent angina pectoris. Ann Thorac Surg (1977) 1.06

A five-year study of viable aortic valve homografts. J Thorac Cardiovasc Surg (1972) 1.06

Mitral valve surgery after previous CABG with functioning IMA grafts. Ann Thorac Surg (1999) 1.06

Five to eight-year follow-up of patients undergoing porcine heart-valve replacement. N Engl J Med (1981) 1.05

Improved surgical approach to left atrial appendage aneurysm. J Card Surg (1992) 1.02

Local cardiac hypothermia for myocardial protection. Ann Thorac Surg (1974) 1.01

Pathologic findings after cardiac valve replacement with glutaraldehyde-fixed porcine valves. Am J Cardiol (1977) 1.01

Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. Circulation (1984) 1.01

Use of the augmented ejection fraction to select patients with left ventricular dysfunction for coronary revascularization. J Thorac Cardiovasc Surg (1976) 1.00

The role of rejection and mechanical trauma on valve graft viability. J Thorac Cardiovasc Surg (1971) 0.99

Effects of hypothermia on systemic and organ system metabolism and function. J Surg Res (1976) 0.99

Coronary artery bypass surgery: assessment of revascularization by determination of blood flow and myocardial mass. Am J Cardiol (1974) 0.99

Ischemic myocardial injury with aortic valve replacement and coronary bypass. Arch Surg (1974) 0.98

Early and late risk of mitral valve replacement. A 12 year concomitant comparison of the porcine bioprosthetic and prosthetic disc mitral valves. J Thorac Cardiovasc Surg (1985) 0.98

Unstable angina: comparison of medical and surgical management. Am J Cardiol (1977) 0.98

Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovasc Surg (1997) 0.97

Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg (1988) 0.97

Heart transplantation for intractable prosthetic valve endocarditis. J Heart Transplant (1990) 0.97

Valve replacement: present status of homograft valves. Prog Cardiovasc Dis (1973) 0.97

Aorto-coronary bypass for acute coronary occlusion. J Thorac Cardiovasc Surg (1972) 0.97

Mitral valve repair in cardiomyopathy. Circulation (1998) 0.97

Long-term survival of more than 2,000 patients after coronary artery bypass grafting. Am J Cardiol (1986) 0.96

Long-term failure rate and morphologic correlations in porcine bioprosthetic heart valves. Am J Cardiol (1983) 0.96

ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. American College of Cardiology/American Heart Association Ad Hoc Task Force on Cardiac Catheterization. Circulation (1991) 0.96

Cardiac valve replacement with the stabilized glutaraldehyde porcine aortic valve: indications, operative results, and followup. Chest (1975) 0.95

Recovery and viability of an acute myocardial infarct after transmyocardial laser revascularization. J Am Coll Cardiol (1995) 0.94

Organ viability with hypothermia. J Thorac Cardiovasc Surg (1969) 0.94

Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation (1987) 0.93

Aortic valve replacement with the fresh valve homograft. Am J Surg (1968) 0.93

Preoperative assessment of aortic regurgitation in patients with mitral valve disease. Am J Cardiol (1967) 0.93

Surgical treatment of nontuberculous empyema. Arch Surg (1970) 0.92

Determinants of operative survival following combined mitral valve replacement and coronary revascularization. Ann Thorac Surg (1982) 0.92

Pneumococcal aortitis in the antibiotic era. Arch Intern Med (1995) 0.92

Aprotinin in primary valve replacement and reconstruction: a multicenter, double-blind, placebo-controlled trial. J Thorac Cardiovasc Surg (1996) 0.92

Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J (1991) 0.91

Optimal approach to the mitral valve: dissection of the interatrial groove. Ann Thorac Surg (1992) 0.91

Doppler echocardiographic comparison of the Carpentier and Duran anuloplasty rings versus no ring after mitral valve repair for mitral regurgitation. Am J Cardiol (1991) 0.91

Incidence and predictors of tias and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum (1999) 0.91

Ischemic myocardial injury during coronary artery surgery. Am Heart J (1971) 0.90

Resuscitative storage of the cadaver heart transplant. Surg Forum (1966) 0.90

Partial upper re-sternotomy for aortic valve replacement or re-replacement after previous cardiac surgery. Eur J Cardiothorac Surg (2000) 0.90

Operative management of the calcified patent ductus arteriosus. Ann Thorac Surg (1986) 0.90

Dissection of the aorta: pathogenesis, diagnosis, and treatment. Prog Cardiovasc Dis (1981) 0.89

Improved long-term survival after aortocoronary bypass for advanced coronary artery disease. Am J Surg (1975) 0.89

Surgical treatment of post-myocardial infarction ventricular septal defects. J Thorac Cardiovasc Surg (1980) 0.88

Rapid noninvasive diagnosis and surgical repair of acute ascending aortic dissection. Improved survival with less angiography. J Thorac Cardiovasc Surg (1994) 0.88

Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels. Arch Surg (1977) 0.88

Aortic valve endocarditis. Determinants of early survival and late morbidity. Circulation (1994) 0.88

Deterioration of formalin-treated aortic valve heterografts. J Thorac Cardiovasc Surg (1970) 0.88

Conservative operation for mitral insufficiency: critical analysis supported by postoperative hemodynamic studies of 72 patients. J Thorac Cardiovasc Surg (1980) 0.88

Contributions of Thomas Jefferson to American medicine. Am J Surg (1979) 0.87

Surgical residencies reviewed by surgical residents. An analysis of American general surgical training programs by the trainees. Surgery (1980) 0.87

Left thoracotomy and femoro-femoral bypass for reoperative revascularization of the posterior coronary circulation. J Card Surg (1987) 0.87

Ischemic injury before heart transplantation does not cause coronary arteriopathy in experimental isografts. J Heart Lung Transplant (1991) 0.87

Body fluid shifts after cardiopulmonary bypass. I. Effects of congestive heart failure and hemodilution. J Thorac Cardiovasc Surg (1971) 0.87

Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury? J Thorac Cardiovasc Surg (1993) 0.87

Long-term results of multivalve surgery for infective multivalve endocarditis. Eur J Cardiothorac Surg (2001) 0.87